Literature DB >> 17952393

[[Treatment of therapy resistant pemphigus vulgaris with rituximab and immunoglobulins].

C Mühlhoff1, M Megahed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17952393     DOI： 10.1007/s00105-007-1414-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  10 in total

1.  Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma.

Authors:  A Bermúdez; F Marco; E Conde; E Mazo; M Recio; A Zubizarreta
Journal:  Haematologica       Date:  2000-08       Impact factor: 9.941

Review 2.  Long-lived plasma cells and their contribution to autoimmunity.

Authors:  Bimba F Hoyer; Rudolf A Manz; Andreas Radbruch; Falk Hiepe
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 3.  A case for regulatory B cells.

Authors:  Atsushi Mizoguchi; Atul K Bhan
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

4.  Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.

Authors:  A Razzaque Ahmed; Zachary Spigelman; Lisa A Cavacini; Marshall R Posner
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

Review 5.  The adjuvant therapy of pemphigus. An update.

Authors:  J C Bystryn; N M Steinman
Journal:  Arch Dermatol       Date:  1996-02

Review 6.  [Intravenous immunoglobulins in the prevention of infection in children with hematologic-oncologic diseases].

Authors:  T Lehrnbecher
Journal:  Klin Padiatr       Date:  2001-09       Impact factor: 1.349

Review 7.  Rituximab: a monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris.

Authors:  Abdul Kader El Tal; Marshall R Posner; Zachary Spigelman; A Razzaque Ahmed
Journal:  J Am Acad Dermatol       Date:  2006-09       Impact factor: 11.527

8.  Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.

Authors:  Pierre Quartier; Olivier Tournilhac; Christine Archimbaud; Leila Lazaro; Carine Chaleteix; Pascale Millet; Hélène Peigue-Lafeuille; Stéphane Blanche; Alain Fischer; Jean-Laurent Casanova; Philippe Travade; Marc Tardieu
Journal:  Clin Infect Dis       Date:  2003-01-16       Impact factor: 9.079

9.  Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody).

Authors:  Alain Dupuy; Manuelle Viguier; Christophe Bédane; Florence Cordoliani; Sophie Blaise; Françoise Aucouturier; Jean-Marie Bonnetblanc; Patrice Morel; Louis Dubertret; Hervé Bachelez
Journal:  Arch Dermatol       Date:  2004-01

10.  A single cycle of rituximab for the treatment of severe pemphigus.

Authors:  Pascal Joly; Hugo Mouquet; Jean-Claude Roujeau; Michel D'Incan; Danièle Gilbert; Serge Jacquot; Marie-Lise Gougeon; Christophe Bedane; Ralf Muller; Brigitte Dreno; Marie-Sylvie Doutre; Emmanuel Delaporte; Christine Pauwels; Nathalie Franck; Frédéric Caux; Catherine Picard; Emmanuelle Tancrede-Bohin; Philippe Bernard; François Tron; Michael Hertl; Philippe Musette
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.